1. Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy
    Yong Luo et al, 2022, Mathematical Biosciences and Engineering CrossRef
  2. A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1)
    Yidi Sun, 2023, Frontiers in Genetics CrossRef
  3. Diet-Induced Obesity Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma via CX3CL1/CX3CR1 Axis
    Yue Sun et al, 2022, Journal of Immunology Research CrossRef
  4. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
    Xinjie Lu, 2022, Current Medicinal Chemistry CrossRef
  5. Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway
    Danning Wang et al, 2020, Frontiers in Oncology CrossRef
  6. Chemokine Receptor Antagonists: Role in Oncology
    Sean Kraus et al, 2021, Current Oncology Reports CrossRef
  7. Interruption of KLF5 acetylation promotes PTEN-deficient prostate cancer progression by reprogramming cancer-associated fibroblasts
    Baotong Zhang et al, 2024, Journal of Clinical Investigation CrossRef
  8. DNA Hypermethylation-Regulated CX3CL1 Reducing T Cell Infiltration Indicates Poor Prognosis in Wilms Tumour
    Tao Mi et al, 2022, Frontiers in Oncology CrossRef
  9. Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia
    Katarzyna Chamera et al, 2021, Pharmacological Reports CrossRef
  10. How to Target Spinal Metastasis in Experimental Research: An Overview of Currently Used Experimental Mouse Models and Future Prospects
    Claudius Jelgersma et al, 2021, International Journal of Molecular Sciences CrossRef
  11. CX3CL1 Induces Vertebral Microvascular Barrier Dysfunction via the Src/P115-RhoGEF/ROCK Signaling Pathway
    Lei Yi et al, 2020, Frontiers in Cellular Neuroscience CrossRef
  12. Osteoid cell-derived chemokines drive bone-metastatic prostate cancer
    Catherine S. Johnson et al, 2023, Frontiers in Oncology CrossRef
  13. The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
    Apoorvi Chaudhri et al, 2023, Frontiers in Immunology CrossRef